Clinical Trial Update: Major Depressive Disorder With Mixed Features [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for Major Depressive Disorder with mixed features has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: WITHDRAWN